{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:35:51Z","timestamp":1761964551892},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejpb.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T04:47:21Z","timestamp":1395463641000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transdermal delivery of Angiotensin Converting Enzyme inhibitors"],"prefix":"10.1016","volume":"88","author":[{"given":"Fouad","family":"Helal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majella E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. B","key":"10.1016\/j.ejpb.2014.03.007_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0260","volume":"vol. 2","year":"2004"},{"key":"10.1016\/j.ejpb.2014.03.007_b0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1248\/bpb.16.254","article-title":"Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol\u2013ethanol system on hairless rat and human skin","volume":"16","author":"Kobayashi","year":"1993","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2014.03.007_b0020","first-page":"88","article-title":"The effect of pH control on the solubility and partition coefficient of trandolapril","volume":"3","author":"Chika","year":"2012","journal-title":"Int. Res. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0025","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/jps.23660","article-title":"Lisinopril dihydrate: single-crystal X-ray structure and physicochemical characterization of derived solid forms","volume":"102","author":"Sorrenti","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2014.03.007_b0030","series-title":"Current Trends in X-ray Crystallography","article-title":"Novel challenges in crystal engineering: polymorphs and new crystal forms of active pharmaceutical ingredients","author":"Andr\u00e9","year":"2011"},{"key":"10.1016\/j.ejpb.2014.03.007_b0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tca.2012.04.009","article-title":"Physicochemical characterization and decomposition kinetics of trandolapril","volume":"539","author":"Roumeli","year":"2012","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejpb.2014.03.007_b0040","first-page":"1560","article-title":"Perindopril","volume":"vol. 2","author":"Ganellin","year":"1997"},{"key":"10.1016\/j.ejpb.2014.03.007_b0045","series-title":"Foye\u2019s Principles of Medicinal Chemistry","author":"Lemke","year":"2013"},{"key":"10.1016\/j.ejpb.2014.03.007_b0050","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/je400397p","article-title":"The effects of anionic, cationic, and nonionic surfactants on acid\u2013base equilibria of ACE inhibitors","volume":"58","author":"Popovi\u0107","year":"2013","journal-title":"J. Chem. Eng. Data"},{"key":"10.1016\/j.ejpb.2014.03.007_b0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2478\/s11696-007-0010-y","article-title":"Acidity, lipophilicity, solubility, absorption, and polar surface area of some ACE inhibitors","volume":"61","author":"Remko","year":"2007","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejpb.2014.03.007_b0255","unstructured":"British National Formulary, BMJ Group, Pharmaceutical Press, London, UK, 2013."},{"key":"10.1016\/j.ejpb.2014.03.007_b0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00003088-198814040-00002","article-title":"Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases","volume":"14","author":"Duchin","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2014.03.007_b0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2125.1982.tb01991.x","article-title":"Enalapril maleate and a lysine analogue (MK-521): disposition in man","volume":"14","author":"Ulm","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03602538308991383","article-title":"Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man","volume":"14","author":"Ulm","year":"1983","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejpb.2014.03.007_b0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bdd.2510050309","article-title":"Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers","volume":"5","author":"Till","year":"1984","journal-title":"Biopharm. Drug Dispos."},{"issue":"Suppl. 1","key":"10.1016\/j.ejpb.2014.03.007_b0085","first-page":"127","article-title":"DE (1989) The clinical pharmacology of lisinopril","volume":"3","author":"Case","year":"1989","journal-title":"J. Hum. Hypertens."},{"issue":"Suppl. 4","key":"10.1016\/j.ejpb.2014.03.007_b0090","first-page":"538","article-title":"Trandolapril: pharmacokinetics of single oral doses in healthy male volunteers","volume":"23","author":"Lenfant","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl. 4","key":"10.1016\/j.ejpb.2014.03.007_b0095","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/00005344-199406001-00010","article-title":"Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2mg to young and elderly patients with mild-to-moderate hypertension","volume":"23","author":"Arner","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0100","first-page":"128","article-title":"Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril","volume":"35","author":"Bevan","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2165\/00044011-199714050-00006","article-title":"Disposition, elimination and haemodynamic effects of verapamil and trandolapril in patients with fatty liver disease","volume":"14","author":"Siepman","year":"1997","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejpb.2014.03.007_b0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1346-8138.1990.tb01621.x","article-title":"Tiopronin-induced lichenoid eruption in a patient with liver disease and positive patch test reaction to drugs with sulfhydryl group","volume":"17","author":"Kurumaji","year":"1990","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1346-8138.1990.tb01608.x","article-title":"Sulfhydryl drug-induced eruption: a clinical and histological study","volume":"17","author":"Kitamura","year":"1990","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1600-0536.1998.tb05952.x","article-title":"Cutaneous reaction to captopril with positive patch test and lack of cross-sensitivity to enalapril and benazepril","volume":"39","author":"Lluch-Bernal","year":"1998","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejpb.2014.03.007_b0125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF00052560","article-title":"Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive rabbits: preliminary report","volume":"6","author":"Zakzewski","year":"1992","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejpb.2014.03.007_b0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/BF02523856","article-title":"Design and implementation of a constant-current pulsed iontophoretic stimulation device","volume":"34","author":"Zakzewski","year":"1996","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.ejpb.2014.03.007_b0135","first-page":"591","article-title":"Improvement of transdermal permeation of captopril by iontophoresis","volume":"21","author":"Wang","year":"2000","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejpb.2014.03.007_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000183922","article-title":"Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin","volume":"22","author":"Watkinson","year":"2009","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0923-1811(95)00403-F","article-title":"Lyophilized aqueous based polymer matrices for transdermal delivery of captopril","volume":"10","author":"Dubey","year":"1995","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejpb.2014.03.007_b0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(96)04773-4","article-title":"Percutaneous absorption of captorpil from hydrophilic cellulose gel through excised rabbit skin and human skin","volume":"145","author":"Wu","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/03639049809085604","article-title":"Percutaneous absorption of captopril from hydrophilic cellulose derivatives through excised rabbit skin and human skin","volume":"24","author":"Wu","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(00)00557-3","article-title":"Evaluation of pharmacokinetics and pharmacodynamics of captopril from transdermal hydrophilic gels in normotensive rabbits and spontaneously hypertensive rats","volume":"209","author":"Wu","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0378-5173(02)00265-X","article-title":"Effect of antioxidants and anti-irritants on the stability, skin irritation and penetration capacity of captopril gel","volume":"241","author":"Huang","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1081\/DDC-120028711","article-title":"The influence of anti-irritants on captopril hydrophilic gel","volume":"30","author":"Huang","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0175","first-page":"379","article-title":"Development of transdermal matrix system of captopril based on cellulose derivative","volume":"1","author":"Jain","year":"2007","journal-title":"Pharmacolgyonline"},{"key":"10.1016\/j.ejpb.2014.03.007_b0180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1081\/DDC-100107679","article-title":"Effects of adhesives and permeation enhancers on the skin permeation of captopril","volume":"27","author":"Park","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpharm.2010.04.042","article-title":"Inhibition of crystallization in drug-in-adhesive-type transdermal patches","volume":"394","author":"Jain","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0190","first-page":"291","article-title":"Matrix type transdermal therapeutic system containing captopril: formulation optimization, in vitro and ex vivo characterization","volume":"70","author":"Kerimo\u011flu","year":"2013","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/156720108783954860","article-title":"Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer","volume":"5","author":"Aqil","year":"2008","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2014.03.007_b0200","first-page":"274","article-title":"Design and development of hydroxypropyl methylcellulose (HPMC) based polymeric film of enalapril maleate","volume":"2","author":"Gavali","year":"2010","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.ejpb.2014.03.007_b0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12249-009-9230-5","article-title":"Optimization of hydrogels for transdermal delivery of lisinopril by Box\u2013Behnken statistical design","volume":"10","author":"Gannu","year":"2009","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2014.03.007_b0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/10837450903085418","article-title":"Iontophoretic delivery of lisinopril: optimization of process variables by Box\u2013Behnken statistical design","volume":"15","author":"Gannu","year":"2010","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0215","first-page":"567","article-title":"Design and in-vitro evaluation of lisinopril transdermal patches containing HPMC and PVP","volume":"4","author":"Desai","year":"2007","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"10.1016\/j.ejpb.2014.03.007_b0220","first-page":"651","article-title":"Design and in-vitro evaluation of lisinopril transdermal patches containing ethylcellusose\u2013povidone as film formers","volume":"4","author":"Desai","year":"2007","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"10.1016\/j.ejpb.2014.03.007_b0225","first-page":"176","article-title":"Formulation and evaluation of matrix type transdermal system of lisinopril dehydrate","volume":"2","author":"Aleti","year":"2011","journal-title":"IRJP"},{"key":"10.1016\/j.ejpb.2014.03.007_b0230","first-page":"239","article-title":"Iontophoretic permeation of lisinopril at different current densities and drug concentrations","volume":"2","author":"Jain","year":"2012","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2014.03.007_b0235","first-page":"54","article-title":"Development and characterisation of perindopril erbumine proniosomal gel","volume":"2","author":"Kute","year":"2012","journal-title":"Asian J. Pharm. Tech."},{"key":"10.1016\/j.ejpb.2014.03.007_b0240","first-page":"44","article-title":"Matrix-type transdermal drug delivery system of trandolapril: in vitro and ex vivo characterization","volume":"64","author":"Tirunagari","year":"2010","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.ejpb.2014.03.007_b0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2009.09.043","article-title":"Oxybutynin permeation in skin: the influence of drug and solvent activity","volume":"384","author":"Santos","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.03.007_b0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2013.09.019","article-title":"Delivery of ibuprofen to the skin","volume":"457","author":"Patel","year":"2013","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:11:11Z","timestamp":1648671071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0939641114000848"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.03.007","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of Angiotensin Converting Enzyme inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}